Aurobindo Pharma gets USFDA final approval for Perampanel tablets
- USFDA granted final approval for Aurobindo Pharma’s Perampanel tablets
- Aurobindo plans to launch in Q3 FY27; estimated US market size is $67 million
- The approval and launch plan could support Aurobindo Pharma’s US generics business
